The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 10, 2025 in BigBear.ai Holdings Lawsuit - BBAI - BigBear.ai Hldgs ( NYSE:BBAI )
NEW YORK, April 23, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of BigBear.ai Holdings, Inc. BBAI. Shareholders who purchased shares of BBAI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff ...
NativePath Native Berberine Under Review: The Best-Selling OTC Berberine Pills for Weight Loss & Blood Sugar Support
New York, April 23, 2025 ( GLOBE NEWSWIRE ) -- In today's fast-paced world, weight management and blood sugar control have become two of the most pressing health concerns for millions.
Solaris Energy Infrastructure, Inc. Class Action: The Gross Law Firm Reminds Solaris Energy Infrastructure, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 27, 2025 - SEI - Solaris Energy ( NYSE:SEI )
NEW YORK, April 23, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Solaris Energy Infrastructure, Inc. SEI. Shareholders who purchased shares of SEI during the class period listed are encouraged to contact the firm regarding possible lead ...
Alaska Air Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Alaska Air Gr ( NYSE:ALK )
Alaska Air Group, Inc. ALK will release earnings results for the first quarter, after the closing bell on Wednesday, April 23. Analysts expect the Seattle, Washington-based company to report quarterly loss at 77 cents per share, versus a year-ago loss of 92 cents per share.
EmPOWERing Sacramento's Workforce: Masons of California, Cal EPIC and SCUSD Launch Green Career Pathways Program to Support Underserved Students
SACRAMENTO, Calif., April 23, 2025 ( GLOBE NEWSWIRE ) -- The Masons of California, the California Energy, Power, and Innovation Collaborative ( Cal EPIC ) , and Sacramento City Unified School District ( SCUSD ) have announced the launch of the Green Career Pathways program, a transformative new ...
Cerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before June 3, 2025 to Discuss Your Rights - ABBV - AbbVie ( NYSE:ABBV )
NEW YORK, April 23, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Cerevel Therapeutics Holdings, Inc. ABBV. Shareholders who purchased shares of ABBV during the class period listed are encouraged to contact the firm regarding possible lead ...
ZBIO LAWSUIT ALERT: The Gross Law Firm Notifies Zenas BioPharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Zenas BioPharma ( NASDAQ:ZBIO )
NEW YORK, April 23, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Zenas BioPharma, Inc. ZBIO. Shareholders who purchased shares of ZBIO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff ...
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of NET Power, Inc. ( NPWR ) Shareholders - NET Power ( NYSE:NPWR )
NEW YORK, April 23, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of NET Power, Inc. NPWR. Shareholders who purchased shares of NPWR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Bitcoin Has Likely Bottomed At $74,500, $200,000 Is On The Table, Says Arthur Hayes
Hayes expects Bitcoin to decouple from tech stocks and resume behaving as a hedge asset similar to physical gold. Bitcoin's behavior in coming months will hinge on policy shifts, especially around May's deficit data. Feel unsure about the market's next move?
Soligenix's HyBryte™ Shows 75% Response Rate In Skin Cancer Trial, Backed By FDA Funding - Soligenix ( NASDAQ:SNGX )
Soligenix SNGX recently announced an exciting update for its novel skin cancer treatment. The company reports that its flagship product candidate, HyBryte™, is showing impressive results in treating a rare form of skin cancer called cutaneous T-cell lymphoma or CTCL, with 75% of patients seeing ...
